---
title: "Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Insights, Forecast to 2032"
datePublished: Thu Nov 27 2025 12:57:06 GMT+0000 (Coordinated Universal Time)
cuid: cmihfubiv000402jo3kjx05h0
slug: global-d-3-bromocamphorcas-10293-06-8-market-insights-forecast-to-2032

---

# Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Insights, Forecast to 2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>The global D-(+)-3-Bromocamphor (CAS 10293-06-8) market size was valued at USD 12.5 million in 2024. The market is projected to grow from USD 13.8 million in 2025 to USD 21.2 million by 2032, exhibiting a CAGR of 6.3% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/164996/d-3-bromocamphor-market">
            https://www.24chemicalresearch.com/download-sample/164996/d-3-bromocamphor-market</a></b></div><br><p>
</p><p>D-(+)-3-Bromocamphor is a specialized chiral compound derived from camphor, characterized by its distinct stereochemistry and a bromine atom at the 3-position. This compound serves as a crucial chiral building block and <strong>resolution agent</strong> in the synthesis of complex molecules. Its primary function is to induce or control stereoselectivity in chemical reactions, making it invaluable for producing enantiomerically pure substances.</p><p>
</p><p>The market growth is primarily fueled by the robust expansion of the pharmaceutical and fine chemical industries, which demand high-purity chiral intermediates for drug development. The segment for <strong>purity &gt;98%</strong> is gaining significant traction due to stringent regulatory requirements in pharmaceutical manufacturing. However, the Asia-Pacific region, particularly China and Japan, dominates both production and consumption, because of established chemical manufacturing infrastructure and cost advantages. Key players like Tokyo Chemical Industry Co., LTD and Hangzhoudauang Chem are focusing on scaling production capacity to meet the rising global demand from the pharmaceutical intermediate application, which holds the largest market share.</p><p style="text-align:center"><strong>Growing Pharmaceutical Applications</strong></p><p>The global D-(+)-3-Bromocamphor market is primarily driven by increasing demand from the pharmaceutical industry, where this chiral compound serves as a crucial intermediate in synthesizing active pharmaceutical ingredients. Pharmaceutical manufacturers utilize D-(+)-3-Bromocamphor for developing optically pure compounds, particularly in neurological and cardiovascular medications where stereochemistry significantly impacts drug efficacy.</p><p style="text-align:center"><strong>Expansion in Chemical Synthesis</strong></p><p>Advances in asymmetric synthesis methodologies have created substantial growth opportunities for D-(+)-3-Bromocamphor as a versatile chiral auxiliary and resolving agent. The compound's rigid bicyclic structure and defined stereochemistry make it invaluable in organic synthesis laboratories, particularly for academic research and fine chemical production. This expanding application base supports steady market growth across multiple chemical sectors.</p><p><strong>âž¤ The market has demonstrated consistent 4-6% annual growth over the past five years, with particular strength in pharmaceutical intermediates and specialty chemical manufacturing sectors.</strong></p><p>Global research and development expenditures in chiral chemistry continue to rise, further driving demand for high-purity D-(+)-3-Bromocamphor. Government and private funding for pharmaceutical research ensures sustained market growth, with emerging applications in material science and catalysis presenting additional avenues for expansion.</p><p>
</p><p><strong>MARKET CHALLENGES</strong></p><p style="text-align:center"><strong>Technical Production Complexities</strong></p><p>Manufacturing D-(+)-3-Bromocamphor involves complex synthetic pathways requiring specialized equipment and expertise in stereoselective synthesis. The multi-step production process presents significant technical challenges, including maintaining optical purity during scale-up and ensuring consistent enantiomeric excess levels. These manufacturing complexities contribute to higher production costs and potential supply chain vulnerabilities.</p><p><strong>Regulatory Compliance Requirements</strong></p><p>The pharmaceutical-grade D-(+)-3-Bromocamphor market faces stringent regulatory scrutiny, particularly for applications in drug manufacturing. Compliance with Good Manufacturing Practices (GMP) standards and various international regulatory frameworks creates substantial barriers for market participants. Documentation requirements, quality control testing, and facility certifications demand significant investment and expertise.</p><p><strong>Other Challenges</strong></p><p><strong>Supply Chain Vulnerabilities</strong>Raw material availability and pricing volatility for camphor derivatives present ongoing challenges for manufacturers. Geopolitical factors affecting chemical supply chains and transportation logistics can disrupt production schedules and affect market stability.</p><p>
<strong>MARKET RESTRAINTS</strong>
</p><p style="text-align:center"><strong>High Production Costs and Limited Scale</strong></p><p>The specialized nature of D-(+)-3-Bromocamphor production limits economies of scale, resulting in higher per-unit costs compared to more common chemical intermediates. The sophisticated purification techniques required to achieve high enantiomeric purity significantly increase manufacturing expenses. These cost factors restrict market penetration in price-sensitive applications and emerging markets.</p><p style="text-align:center"><strong>Environmental and Safety Regulations</strong></p><p>Stringent environmental regulations governing brominated compound manufacturing and handling present significant market restraints. Compliance with REACH, TSCA, and other chemical safety regulations requires substantial investment in environmental controls and worker safety measures. These regulatory burdens particularly impact smaller manufacturers with limited resources for compliance management.</p><p>Emerging regulatory frameworks for sustainable chemistry and green manufacturing principles may further constrain traditional production methods. The industry faces increasing pressure to develop more environmentally friendly synthesis routes while maintaining product quality and cost competitiveness.</p><p>
<strong>MARKET OPPORTUNITIES</strong>
</p><p style="text-align:center"><strong>Biocatalytic Production Methods</strong></p><p>Development of enzymatic and biocatalytic synthesis routes for D-(+)-3-Bromocamphor represents a significant market opportunity. Biocatalytic methods offer potential advantages in stereoselectivity, reduced environmental impact, and improved process economics. Companies investing in green chemistry technologies are well-positioned to capture market share as sustainability concerns influence purchasing decisions.</p><p style="text-align:center"><strong>Emerging Applications in Material Science</strong></p><p>Research into advanced materials utilizing chiral compounds creates new application areas for D-(+)-3-Bromocamphor. The compound's unique structural properties show promise in liquid crystal displays, chiral stationary phases for chromatography, and specialty polymers. These expanding applications could drive market growth beyond traditional pharmaceutical uses.</p><p>Asia-Pacific regional expansion presents substantial opportunities, particularly in pharmaceutical manufacturing hubs in India and China. Growing domestic capabilities in fine chemical production and increasing research investments create favorable conditions for market growth. Local production facilities could reduce import dependencies and improve supply chain resilience.</p><p>
</p><p>
</p><p>
		
			By Purity Grade Requirement
			
			</p><p>


COMPETITIVE LANDSCAPE</p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>A Concentrated Market Driven by Specialized Chemical Producers</strong></p><p>
</p><p>The global D-(+)-3-Bromocamphor market is characterized by a limited number of specialized manufacturers focusing on fine and pharmaceutical chemicals. The market structure is moderately concentrated, with production capabilities primarily situated in key chemical manufacturing hubs across Asia and North America. Leading players have established their positions through strong technical expertise in chiral compound synthesis and purification, ensuring consistent product quality, particularly the critical &gt;98% purity grade demanded by the pharmaceutical industry. Competition is largely based on product purity, reliable supply chains, and adherence to the stringent quality control standards required for intermediates used in pharmaceutical applications. These established companies leverage their expertise in complex organic synthesis and dedicated production facilities to serve a global clientele.</p><p>
</p><p>Beyond the primary producers, a niche segment of the market is served by global chemical distributors and suppliers who act as key intermediaries, ensuring product accessibility for research institutions and smaller-scale industrial users. Companies like Tokyo Chemical Industry Co., LTD play a significant role in this segment by providing high-purity materials for research and development purposes. While the barrier to entry for new producers is high due to the specialized synthesis process and quality requirements, there is potential for regional chemical manufacturers to emerge by targeting specific geographic markets or developing more cost-effective production methodologies for standard purity grades used in broader organic synthesis applications.</p><p>
<strong>List of Key D-(+)-3-Bromocamphor Companies Profiled</strong></p><p>
</p><p>Hangzhoudauang Chem (China)</p><p>Tokyo Chemical Industry Co., LTD (Japan)</p><p>Hairui (China)</p><p>Norna Group (China)</p><p>Yonghe Chemical (China)</p><p>


    Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Trends
</p><p>

<strong>Dominance of High-Purity Grades and Application in Pharmaceutical Intermediates</strong></p><p>
</p><p>The global D-(+)-3-Bromocamphor market is characterized by a significant trend towards the consumption of high-purity grades, specifically material with a purity level exceeding 98%. This shift is directly driven by the stringent quality requirements of its primary application in pharmaceutical intermediates. As pharmaceutical companies increasingly demand high-specification chiral building blocks for the synthesis of complex active pharmaceutical ingredients (APIs), suppliers like Tokyo Chemical Industry Co., LTD and Hangzhoudauang Chem are focusing their production capabilities on meeting this demand. The segment for 'purity &gt;98%' is expected to witness the most substantial growth rate in the coming years, reflecting the industry's move towards more sophisticated and regulated end-products.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Expansion of Production Capacities in Asia-Pacific</strong></p><p>
</p><p>Key production of D-(+)-3-Bromocamphor is concentrated in regions including China and Japan. There is a discernible trend of capacity expansion by manufacturers in the Asia-Pacific region to cater to the growing global consumption. This is supported by the region's robust chemical manufacturing infrastructure and cost-effective production environment. Companies such as Yonghe Chemical and Hairui are strategically positioned to increase their market share by scaling up operations to serve not only regional demand from countries like India and South Korea but also export markets in North America and Europe.</p><p>
</p><p><strong>Increasing Consumption in Research and Specialty Organic Synthesis</strong></p><p>
</p><p>Beyond its well-established role as a pharmaceutical intermediate, D-(+)-3-Bromocamphor is experiencing steady demand from the broader organic synthesis sector. The compound's specific chiral properties make it a valuable intermediate in academic research and the development of specialty chemicals. This 'Others' application segment, while smaller than the pharmaceutical segment, contributes to a diversified demand base, making the market less susceptible to fluctuations in a single industry. The consistent requirement from research institutions and niche chemical manufacturers provides a stable foundation for market growth.</p><p>
<strong>Strategic Focus on Supply Chain Robustness</strong></p><p>
</p><p>Recent global supply chain disruptions have underscored the importance of reliable sourcing for critical chemical intermediates. A key trend among major stakeholders in the D-(+)-3-Bromocamphor market is the strategic emphasis on building resilient and diversified supply chains. This involves establishing multiple production sites and securing raw material inputs to mitigate regional risks. Players like Norna Group are focusing on ensuring consistent supply to key consumption regions such as North America and Europe, where demand from the pharmaceutical industry remains strong. This trend towards supply chain optimization is becoming a critical competitive differentiator in the market.</p><p>

Regional Analysis: Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market</p><p>


  
    Asia-Pacific
    
      Asia-Pacific stands as the dominant force in the global D-(+)-3-Bromocamphor market, driven by its robust chemical manufacturing base. The region, particularly China, is a major production hub, with companies like Yonghe Chemical and Norna Group having significant operations. This strong production capacity ensures a steady and cost-effective supply of the chemical for both domestic consumption and international exports. The demand within Asia-Pacific is fueled by a rapidly expanding pharmaceutical industry, where the compound is utilized as a key intermediate, and a growing market for fine chemicals used in organic synthesis. Furthermore, well-established supply chains and continuous investments in chemical research and development within countries like Japan, South Korea, and India contribute to the region's leadership, solidifying its pivotal role in the global market landscape.
    
  
  
  
    
      Asia-Pacific: Production Leadership</p><p>
      Asia-Pacific's dominance is anchored by its substantial production capacity for D-(+)-3-Bromocamphor, primarily concentrated in China and Japan. This regional strength provides a stable supply chain for global markets. The presence of key manufacturers supports not only local demand but also large-scale exports, making the region the foremost production center and a critical supplier to the international chemical industry.
    
    
      Asia-Pacific: Demand Drivers</p><p>
      The regional demand is primarily driven by the pharmaceutical and organic synthesis sectors. The compound's role as a chiral building block in drug development aligns with the growth of Asia's pharmaceutical industry. Additionally, its use in various organic synthesis applications for producing fine chemicals and specialty materials creates consistent and growing consumption within the region.
    
    
      Asia-Pacific: Supply Chain &amp; Infrastructure</p><p>
      The region benefits from a mature and efficient chemical supply chain infrastructure. This includes advanced logistics networks, specialized chemical handling facilities, and proximity to raw material sources. This robust infrastructure enables efficient distribution and supports the region's position as a reliable and competitive player in the global D-(+)-3-Bromocamphor market.
    
    
      Asia-Pacific: Regulatory and Research Environment</p><p>
      Supportive industrial policies and a strong focus on chemical research and development in countries like China, Japan, and South Korea foster innovation and process optimization for chemicals like D-(+)-3-Bromocamphor. This environment encourages technological advancements and ensures compliance with international quality standards, enhancing the region's competitiveness and market appeal.
    
  
</p><p>
</p><p><strong>North America</strong></p><p>
North America represents a significant market for D-(+)-3-Bromocamphor, characterized by high-value applications in pharmaceutical research and development. The region's market is driven by a sophisticated pharmaceutical sector and a strong presence of research institutions that utilize the compound as a critical intermediate. While domestic production capacity is more limited compared to Asia-Pacific, the region maintains a stable supply through imports. Demand is steadied by stringent regulatory standards which ensure high-purity requirements, particularly for pharmaceutical use. The market dynamics are influenced by ongoing R&amp;D activities and the need for high-quality specialty chemicals in advanced manufacturing processes.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe holds a well-established position in the D-(+)-3-Bromocamphor market, supported by a robust chemical industry and significant demand from the pharmaceutical and fine chemicals sectors. Countries like Germany, France, and the U.K. are key consumers, with a focus on high-quality intermediates for sophisticated synthesis applications. The market is characterized by stringent environmental and safety regulations, which shape both production standards and consumption patterns. European demand is sustained by continuous innovation in life sciences and a strong export-oriented chemical industry, though it relies on a mix of regional production and imports to meet its needs.</p><p>
</p><p><strong>Latin America</strong></p><p>
The Latin American market for D-(+)-3-Bromocamphor is emerging, with growth potential linked to the developing pharmaceutical and chemical industries in countries like Brazil and Mexico. Market dynamics are influenced by increasing regional investments in industrial capabilities and a gradual rise in domestic consumption for synthesis applications. The region currently depends significantly on imports to fulfill demand. Growth is tempered by economic fluctuations and evolving regulatory frameworks, but the long-term outlook is positive as local industries continue to advance and integrate into global supply chains.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
The Middle East &amp; Africa region represents a smaller but developing market for D-(+)-3-Bromocamphor. Demand is primarily driven by niche applications in academic research and a nascent pharmaceutical sector, particularly in countries like Saudi Arabia and South Africa. The market is largely import-dependent, with limited local manufacturing capacity. Growth is gradual, influenced by regional economic diversification efforts and increasing investment in chemical and pharmaceutical infrastructure, which may lead to higher future consumption.</p><p>


<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for D-(+)-3-Bromocamphor(CAS 10293-06-8), covering the period from 2025 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Production capacity, revenue, and sales volume forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed D-(+)-3-Bromocamphor companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market was valued at <strong>USD 13.8 million in 2025</strong> and is expected to reach <strong>USD 21.2 million by 2032</strong>.</p><p>
<strong>Which key companies operate in Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Hangzhoudauang Chem, Tokyo Chemical Industry Co., LTD, Hairui, Norna Group, and Yonghe Chemical</strong>, among others.</p><p>
<strong>What are the key growth drivers of Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>robust expansion of the pharmaceutical and fine chemical industries and demand for high-purity chiral intermediates for drug development</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Asia-Pacific</strong> is the dominant market, with major production and consumption in China and Japan.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>increasing demand for the high-purity segment (&gt;98%) due to stringent pharmaceutical regulations and scaling of production capacity by key players</strong>.</p><p>

</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/164996/d-3-bromocamphor-market">
            https://www.24chemicalresearch.com/reports/164996/d-3-bromocamphor-market</a></b></div><br>
            <b>Table of Content:</b><p>1 Study Coverage<br />
    1.1 D-(+)-3-Bromocamphor(CAS 10293-06-8) Product Introduction<br />
    1.2 Market by Type<br />
        1.2.1 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size by Type, 2017 VS 2021 VS 2028<br />
        1.2.2 purity >98%<br />
        1.2.3 purity=98%<br />
    1.3 Market by Application<br />
        1.3.1 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size by Application, 2017 VS 2021 VS 2028<br />
        1.3.2 Organic Synthesis Intermediate<br />
        1.3.3 Pharmaceutical Intermediate<br />
        1.3.4 Others<br />
    1.4 Study Objectives<br />
    1.5 Years Considered<br />
2 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Production<br />
    2.1 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Production Capacity (2017-2028)<br />
    2.2 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Production by Region: 2017 VS 2021 VS 2028<br />
    2.3 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Production by Region<br />
        2.3.1 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Historic Production by Region (2017-2022)<br />
        2.3.2 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Forecasted Production by Region (2023-2028)<br />
    2.4 North America<br />
    2.5 China<br />
    2.6 Japan<br />
3 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Sales in Volume & Value Estimates and Forecasts<br />
    3.1 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Sales Estimates and Forecasts 2017-2028<br />
    3.2 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Revenue Estimates and Forecasts 2017-2028<br />
    3.3 Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Revenue by Region: 2017 VS 202</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/164996/d-3-bromocamphor-market">
            https://www.24chemicalresearch.com/reports/164996/d-3-bromocamphor-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>